Turn Therapeutics TTRX
NASDAQ TTRX
$9.72 -0.07 (-0.72%)
As of: Nov 10, 2026 · 2:36 PM EST

Turn Therapeutics (TTRX) Debt Ratio (2026)

Updated

Turn Therapeutics' Debt Ratio was 0.36 in Q2 2026, up 12.3% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Debt Ratio (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 0.33
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.23
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 0.55
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 0.41
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 0.08
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 0.28
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 0.56
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 0.51
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 0.31
10 Turn Therapeutics 300.41 Mn 273.52 Mn - 0.36
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.36
Mar 31, 2026 0.32
API Access

Turn Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TTRX&period=max&api_key=YOUR_API_KEY